Sign in
bf/NASDAQ:CYT_icon.jpeg

NASDAQ:CYT

Cyteir Therapeutics, Inc.

  • Stock

USD

Last Close

3.09

15/03 20:00

Market Cap

108.71M

Beta: -

Volume Today

1.01M

Avg: 56.88K

PE Ratio

−3.67

PFCF: −4.34

OverviewFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
asset turnover
cash per share
1.49
-
0.46
69.33%
9.73
2,025.12%
4.17
57.13%
company equity multiplier
-1.11
-
-0.29
74.17%
1.04
464.81%
1.05
0.41%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
0.93
-
0.99
6.44%
1.00
0.26%
0.96
4.08%
effective tax rate
0.01
-
0.05
302.68%
enterprise value multiple
-19.45
-
-19.66
1.03%
-0.76
96.15%
1.83
341.46%
fixed asset turnover
free cash flow per share
-0.91
-
-0.81
10.84%
-1.91
135.20%
-1.21
36.37%
gross profit margin
interest coverage
72.11
-
inventory turnover
long term debt to capitalization
net income per ebt
1
-
1
0%
0.99
1.14%
0.95
3.48%
net profit margin
operating cash flow per share
-0.90
-
-0.78
14.10%
-1.85
138.12%
-1.21
34.75%
operating profit margin
payables turnover
pretax profit margin
price fair value
-11.93
-
-8.65
27.48%
1.18
113.68%
0.40
66.39%
receivables turnover
return on assets
-0.48
-
-1.52
216.12%
-0.21
85.94%
-0.29
34.57%
return on capital employed
-0.55
-
-1.98
260.71%
-0.22
88.62%
-0.33
44.78%
return on equity
0.53
-
0.43
18.34%
-0.22
151.29%
-0.30
35.12%
total debt to capitalization
0.01
-

All numbers in USD (except ratios and percentages)